Intellia Therapeutics, Inc. · NASDAQ:NTLA

Vanguard Capital Management LLC reported a 5.03% stake in Intellia Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed Apr 30, 2026

Vanguard Capital Management LLC reported a 5.03% stake in Intellia Therapeutics, Inc., 5,945,571 shares, as a passive investor on Mar 31, 2026. Filed Apr 30, 2026 (Schedule 13G).

Stake
5.03%
Shares
5,945,571
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Vanguard Capital Management5.03%5,945,571

Source

View original at SEC

Related